Amoxicillin/Clavulanic acid Centrient

Medicinal product

(Invented) name

Active substance (s)

Amoksicilinas/Klavulano rūgštis

Strength

200 mg/28,5 mg/5 ml

Pharmaceutical form

milteliai geriamajai suspensijai

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

J01CR02, Amoxicillin and beta-lactamase inhibitor

Marketing authorisation holder

Centrient Pharmaceuticals Netherlands B.V., Nyderlandai

Date of authorisation

2021-08-13

Date of renewal

Documents

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

5 ml paruoštos suspensijos yra :	5 ml
Amoksicilinas	200 mg
Klavulano rūgštis	28,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To
107101	93204	1093204	buteliukas	70 ml, geriamasis švirkštas (6 ml), matavimo šaukštas/ taurelė (5 ml) N1	Receptinis	LT/1/21/4800/001	Netiekiama	-	-	No	-	-
107102	93205	1093205	buteliukas	100 ml, geriamasis švirkštas (6 ml), matavimo šaukštas/ taurelė (5 ml) N1	Receptinis	LT/1/21/4800/002	Netiekiama	-	-	No	-	-
107103	93206	1093206	buteliukas	140 ml, geriamasis švirkštas (6 ml), matavimo šaukštas/ taurelė (5 ml) N1	Receptinis	LT/1/21/4800/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-08-13	Registruotas